Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
1,251
archived clinical trials in
Pneumonia

A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 When Administered Concomitantly With Influenza Vaccine in Healthy Adults 50 Years of Age or Older (V114-021/PNEU-FLU)
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 When Administered Concomitantly With Influenza Vaccine in Healthy Adults 50 Years of Age or Older (PNEU-FLU)
Status: Enrolling
Updated:  12/31/1969
Mid Hudson Medical Research
mi
from
New Windsor, NY
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 When Administered Concomitantly With Influenza Vaccine in Healthy Adults 50 Years of Age or Older (V114-021/PNEU-FLU)
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 When Administered Concomitantly With Influenza Vaccine in Healthy Adults 50 Years of Age or Older (PNEU-FLU)
Status: Enrolling
Updated: 12/31/1969
Mid Hudson Medical Research
mi
from
New Windsor, NY
Click here to add this to my saved trials
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 When Administered Concomitantly With Influenza Vaccine in Healthy Adults 50 Years of Age or Older (V114-021/PNEU-FLU)
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 When Administered Concomitantly With Influenza Vaccine in Healthy Adults 50 Years of Age or Older (PNEU-FLU)
Status: Enrolling
Updated:  12/31/1969
Rochester Clinical Research Inc.
mi
from
Rochester, NY
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 When Administered Concomitantly With Influenza Vaccine in Healthy Adults 50 Years of Age or Older (V114-021/PNEU-FLU)
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 When Administered Concomitantly With Influenza Vaccine in Healthy Adults 50 Years of Age or Older (PNEU-FLU)
Status: Enrolling
Updated: 12/31/1969
Rochester Clinical Research Inc.
mi
from
Rochester, NY
Click here to add this to my saved trials
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 When Administered Concomitantly With Influenza Vaccine in Healthy Adults 50 Years of Age or Older (V114-021/PNEU-FLU)
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 When Administered Concomitantly With Influenza Vaccine in Healthy Adults 50 Years of Age or Older (PNEU-FLU)
Status: Enrolling
Updated:  12/31/1969
Unity Clinical Research
mi
from
Lindsay, OK
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 When Administered Concomitantly With Influenza Vaccine in Healthy Adults 50 Years of Age or Older (V114-021/PNEU-FLU)
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 When Administered Concomitantly With Influenza Vaccine in Healthy Adults 50 Years of Age or Older (PNEU-FLU)
Status: Enrolling
Updated: 12/31/1969
Unity Clinical Research
mi
from
Lindsay, OK
Click here to add this to my saved trials
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 When Administered Concomitantly With Influenza Vaccine in Healthy Adults 50 Years of Age or Older (V114-021/PNEU-FLU)
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 When Administered Concomitantly With Influenza Vaccine in Healthy Adults 50 Years of Age or Older (PNEU-FLU)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Center of Reading, LLP
mi
from
Wyomissing, PA
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 When Administered Concomitantly With Influenza Vaccine in Healthy Adults 50 Years of Age or Older (V114-021/PNEU-FLU)
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 When Administered Concomitantly With Influenza Vaccine in Healthy Adults 50 Years of Age or Older (PNEU-FLU)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Center of Reading, LLP
mi
from
Wyomissing, PA
Click here to add this to my saved trials
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 When Administered Concomitantly With Influenza Vaccine in Healthy Adults 50 Years of Age or Older (V114-021/PNEU-FLU)
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 When Administered Concomitantly With Influenza Vaccine in Healthy Adults 50 Years of Age or Older (PNEU-FLU)
Status: Enrolling
Updated:  12/31/1969
Omega Medical Research
mi
from
Warwick, RI
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 When Administered Concomitantly With Influenza Vaccine in Healthy Adults 50 Years of Age or Older (V114-021/PNEU-FLU)
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 When Administered Concomitantly With Influenza Vaccine in Healthy Adults 50 Years of Age or Older (PNEU-FLU)
Status: Enrolling
Updated: 12/31/1969
Omega Medical Research
mi
from
Warwick, RI
Click here to add this to my saved trials
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 When Administered Concomitantly With Influenza Vaccine in Healthy Adults 50 Years of Age or Older (V114-021/PNEU-FLU)
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 When Administered Concomitantly With Influenza Vaccine in Healthy Adults 50 Years of Age or Older (PNEU-FLU)
Status: Enrolling
Updated:  12/31/1969
PMG Research Inc ( Site 0027)
mi
from
Mount Pleasant, SC
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 When Administered Concomitantly With Influenza Vaccine in Healthy Adults 50 Years of Age or Older (V114-021/PNEU-FLU)
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 When Administered Concomitantly With Influenza Vaccine in Healthy Adults 50 Years of Age or Older (PNEU-FLU)
Status: Enrolling
Updated: 12/31/1969
PMG Research Inc ( Site 0027)
mi
from
Mount Pleasant, SC
Click here to add this to my saved trials
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 When Administered Concomitantly With Influenza Vaccine in Healthy Adults 50 Years of Age or Older (V114-021/PNEU-FLU)
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 When Administered Concomitantly With Influenza Vaccine in Healthy Adults 50 Years of Age or Older (PNEU-FLU)
Status: Enrolling
Updated:  12/31/1969
Holston Medical Group
mi
from
Bristol, TN
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 When Administered Concomitantly With Influenza Vaccine in Healthy Adults 50 Years of Age or Older (V114-021/PNEU-FLU)
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 When Administered Concomitantly With Influenza Vaccine in Healthy Adults 50 Years of Age or Older (PNEU-FLU)
Status: Enrolling
Updated: 12/31/1969
Holston Medical Group
mi
from
Bristol, TN
Click here to add this to my saved trials
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 When Administered Concomitantly With Influenza Vaccine in Healthy Adults 50 Years of Age or Older (V114-021/PNEU-FLU)
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 When Administered Concomitantly With Influenza Vaccine in Healthy Adults 50 Years of Age or Older (PNEU-FLU)
Status: Enrolling
Updated:  12/31/1969
Holston Medical Group, PC
mi
from
Kingsport, TN
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 When Administered Concomitantly With Influenza Vaccine in Healthy Adults 50 Years of Age or Older (V114-021/PNEU-FLU)
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 When Administered Concomitantly With Influenza Vaccine in Healthy Adults 50 Years of Age or Older (PNEU-FLU)
Status: Enrolling
Updated: 12/31/1969
Holston Medical Group, PC
mi
from
Kingsport, TN
Click here to add this to my saved trials
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 When Administered Concomitantly With Influenza Vaccine in Healthy Adults 50 Years of Age or Older (V114-021/PNEU-FLU)
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 When Administered Concomitantly With Influenza Vaccine in Healthy Adults 50 Years of Age or Older (PNEU-FLU)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Associates
mi
from
Nashville, TN
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 When Administered Concomitantly With Influenza Vaccine in Healthy Adults 50 Years of Age or Older (V114-021/PNEU-FLU)
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 When Administered Concomitantly With Influenza Vaccine in Healthy Adults 50 Years of Age or Older (PNEU-FLU)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Associates
mi
from
Nashville, TN
Click here to add this to my saved trials
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 When Administered Concomitantly With Influenza Vaccine in Healthy Adults 50 Years of Age or Older (V114-021/PNEU-FLU)
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 When Administered Concomitantly With Influenza Vaccine in Healthy Adults 50 Years of Age or Older (PNEU-FLU)
Status: Enrolling
Updated:  12/31/1969
Wellness Clinical Research Associates ( Site 0048)
mi
from
Allen, TX
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 When Administered Concomitantly With Influenza Vaccine in Healthy Adults 50 Years of Age or Older (V114-021/PNEU-FLU)
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 When Administered Concomitantly With Influenza Vaccine in Healthy Adults 50 Years of Age or Older (PNEU-FLU)
Status: Enrolling
Updated: 12/31/1969
Wellness Clinical Research Associates ( Site 0048)
mi
from
Allen, TX
Click here to add this to my saved trials
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 When Administered Concomitantly With Influenza Vaccine in Healthy Adults 50 Years of Age or Older (V114-021/PNEU-FLU)
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 When Administered Concomitantly With Influenza Vaccine in Healthy Adults 50 Years of Age or Older (PNEU-FLU)
Status: Enrolling
Updated:  12/31/1969
Benchmark Research
mi
from
Fort Worth, TX
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 When Administered Concomitantly With Influenza Vaccine in Healthy Adults 50 Years of Age or Older (V114-021/PNEU-FLU)
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 When Administered Concomitantly With Influenza Vaccine in Healthy Adults 50 Years of Age or Older (PNEU-FLU)
Status: Enrolling
Updated: 12/31/1969
Benchmark Research
mi
from
Fort Worth, TX
Click here to add this to my saved trials
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 When Administered Concomitantly With Influenza Vaccine in Healthy Adults 50 Years of Age or Older (V114-021/PNEU-FLU)
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 When Administered Concomitantly With Influenza Vaccine in Healthy Adults 50 Years of Age or Older (PNEU-FLU)
Status: Enrolling
Updated:  12/31/1969
San Gabriel Clinical Research
mi
from
Georgetown, TX
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 When Administered Concomitantly With Influenza Vaccine in Healthy Adults 50 Years of Age or Older (V114-021/PNEU-FLU)
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 When Administered Concomitantly With Influenza Vaccine in Healthy Adults 50 Years of Age or Older (PNEU-FLU)
Status: Enrolling
Updated: 12/31/1969
San Gabriel Clinical Research
mi
from
Georgetown, TX
Click here to add this to my saved trials
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 When Administered Concomitantly With Influenza Vaccine in Healthy Adults 50 Years of Age or Older (V114-021/PNEU-FLU)
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 When Administered Concomitantly With Influenza Vaccine in Healthy Adults 50 Years of Age or Older (PNEU-FLU)
Status: Enrolling
Updated:  12/31/1969
Charlottesville Medical Research Center, LLC
mi
from
Charlottesville, VA
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 When Administered Concomitantly With Influenza Vaccine in Healthy Adults 50 Years of Age or Older (V114-021/PNEU-FLU)
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 When Administered Concomitantly With Influenza Vaccine in Healthy Adults 50 Years of Age or Older (PNEU-FLU)
Status: Enrolling
Updated: 12/31/1969
Charlottesville Medical Research Center, LLC
mi
from
Charlottesville, VA
Click here to add this to my saved trials
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 When Administered Concomitantly With Influenza Vaccine in Healthy Adults 50 Years of Age or Older (V114-021/PNEU-FLU)
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 When Administered Concomitantly With Influenza Vaccine in Healthy Adults 50 Years of Age or Older (PNEU-FLU)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Partners
mi
from
Richmond, VA
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 When Administered Concomitantly With Influenza Vaccine in Healthy Adults 50 Years of Age or Older (V114-021/PNEU-FLU)
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 When Administered Concomitantly With Influenza Vaccine in Healthy Adults 50 Years of Age or Older (PNEU-FLU)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Partners
mi
from
Richmond, VA
Click here to add this to my saved trials
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 When Administered Concomitantly With Influenza Vaccine in Healthy Adults 50 Years of Age or Older (V114-021/PNEU-FLU)
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 When Administered Concomitantly With Influenza Vaccine in Healthy Adults 50 Years of Age or Older (PNEU-FLU)
Status: Enrolling
Updated:  12/31/1969
Allegiance Research Specialists
mi
from
Wauwatosa, WI
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 When Administered Concomitantly With Influenza Vaccine in Healthy Adults 50 Years of Age or Older (V114-021/PNEU-FLU)
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 When Administered Concomitantly With Influenza Vaccine in Healthy Adults 50 Years of Age or Older (PNEU-FLU)
Status: Enrolling
Updated: 12/31/1969
Allegiance Research Specialists
mi
from
Wauwatosa, WI
Click here to add this to my saved trials
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 When Administered Concomitantly With Influenza Vaccine in Healthy Adults 50 Years of Age or Older (V114-021/PNEU-FLU)
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 When Administered Concomitantly With Influenza Vaccine in Healthy Adults 50 Years of Age or Older (PNEU-FLU)
Status: Enrolling
Updated:  12/31/1969
Synexus Clinical Research US, Inc./Colorado Springs Family Practice ( Site 0021)
mi
from
Colorado Springs, CO
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 When Administered Concomitantly With Influenza Vaccine in Healthy Adults 50 Years of Age or Older (V114-021/PNEU-FLU)
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 When Administered Concomitantly With Influenza Vaccine in Healthy Adults 50 Years of Age or Older (PNEU-FLU)
Status: Enrolling
Updated: 12/31/1969
Synexus Clinical Research US, Inc./Colorado Springs Family Practice ( Site 0021)
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 When Administered Concomitantly With Influenza Vaccine in Healthy Adults 50 Years of Age or Older (V114-021/PNEU-FLU)
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 When Administered Concomitantly With Influenza Vaccine in Healthy Adults 50 Years of Age or Older (PNEU-FLU)
Status: Enrolling
Updated:  12/31/1969
PMG Research of Cary
mi
from
Cary, NC
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 When Administered Concomitantly With Influenza Vaccine in Healthy Adults 50 Years of Age or Older (V114-021/PNEU-FLU)
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 When Administered Concomitantly With Influenza Vaccine in Healthy Adults 50 Years of Age or Older (PNEU-FLU)
Status: Enrolling
Updated: 12/31/1969
PMG Research of Cary
mi
from
Cary, NC
Click here to add this to my saved trials
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 When Administered Concomitantly With Influenza Vaccine in Healthy Adults 50 Years of Age or Older (V114-021/PNEU-FLU)
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 When Administered Concomitantly With Influenza Vaccine in Healthy Adults 50 Years of Age or Older (PNEU-FLU)
Status: Enrolling
Updated:  12/31/1969
Synexus Clinical Research US, Inc. ( Site 0019)
mi
from
San Antonio, TX
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 When Administered Concomitantly With Influenza Vaccine in Healthy Adults 50 Years of Age or Older (V114-021/PNEU-FLU)
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 When Administered Concomitantly With Influenza Vaccine in Healthy Adults 50 Years of Age or Older (PNEU-FLU)
Status: Enrolling
Updated: 12/31/1969
Synexus Clinical Research US, Inc. ( Site 0019)
mi
from
San Antonio, TX
Click here to add this to my saved trials
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 When Administered Concomitantly With Influenza Vaccine in Healthy Adults 50 Years of Age or Older (V114-021/PNEU-FLU)
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 When Administered Concomitantly With Influenza Vaccine in Healthy Adults 50 Years of Age or Older (PNEU-FLU)
Status: Enrolling
Updated:  12/31/1969
Synexus Clinical Research US, Inc. ( Site 0039)
mi
from
Chandler, AZ
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 When Administered Concomitantly With Influenza Vaccine in Healthy Adults 50 Years of Age or Older (V114-021/PNEU-FLU)
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 When Administered Concomitantly With Influenza Vaccine in Healthy Adults 50 Years of Age or Older (PNEU-FLU)
Status: Enrolling
Updated: 12/31/1969
Synexus Clinical Research US, Inc. ( Site 0039)
mi
from
Chandler, AZ
Click here to add this to my saved trials
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 When Administered Concomitantly With Influenza Vaccine in Healthy Adults 50 Years of Age or Older (V114-021/PNEU-FLU)
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 When Administered Concomitantly With Influenza Vaccine in Healthy Adults 50 Years of Age or Older (PNEU-FLU)
Status: Enrolling
Updated:  12/31/1969
Synexus Clinical Research, US,Inc/Central Arizona Medical Associates, PC ( Site 0004)
mi
from
Mesa, AZ
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 When Administered Concomitantly With Influenza Vaccine in Healthy Adults 50 Years of Age or Older (V114-021/PNEU-FLU)
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 When Administered Concomitantly With Influenza Vaccine in Healthy Adults 50 Years of Age or Older (PNEU-FLU)
Status: Enrolling
Updated: 12/31/1969
Synexus Clinical Research, US,Inc/Central Arizona Medical Associates, PC ( Site 0004)
mi
from
Mesa, AZ
Click here to add this to my saved trials
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 When Administered Concomitantly With Influenza Vaccine in Healthy Adults 50 Years of Age or Older (V114-021/PNEU-FLU)
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 When Administered Concomitantly With Influenza Vaccine in Healthy Adults 50 Years of Age or Older (PNEU-FLU)
Status: Enrolling
Updated:  12/31/1969
Synexus Clinical Research US, Inc. ( Site 0042)
mi
from
Scottsdale, AZ
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 When Administered Concomitantly With Influenza Vaccine in Healthy Adults 50 Years of Age or Older (V114-021/PNEU-FLU)
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 When Administered Concomitantly With Influenza Vaccine in Healthy Adults 50 Years of Age or Older (PNEU-FLU)
Status: Enrolling
Updated: 12/31/1969
Synexus Clinical Research US, Inc. ( Site 0042)
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 When Administered Concomitantly With Influenza Vaccine in Healthy Adults 50 Years of Age or Older (V114-021/PNEU-FLU)
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 When Administered Concomitantly With Influenza Vaccine in Healthy Adults 50 Years of Age or Older (PNEU-FLU)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Center of Neveda, LLC. ( Site 0022)
mi
from
Las Vegas, NV
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 When Administered Concomitantly With Influenza Vaccine in Healthy Adults 50 Years of Age or Older (V114-021/PNEU-FLU)
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 When Administered Concomitantly With Influenza Vaccine in Healthy Adults 50 Years of Age or Older (PNEU-FLU)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Center of Neveda, LLC. ( Site 0022)
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Comparison of Telavancin and Vancomycin for Hospital-acquired Pneumonia Due to Methicillin-resistant Staphylococcus Aureus
A Phase 3, Randomized, Double-Blind, Parallel-Group, Multinational Trial of Intravenous Telavancin Versus Vancomycin for Treatment of Hospital-Acquired Pneumonia With a Focus on Patients With Infections Due to Methicillin-Resistant Staphylococcus Aureus
Status: Enrolling
Updated:  12/31/1969
Baystate Medical Center
mi
from
Springfield, MA
Comparison of Telavancin and Vancomycin for Hospital-acquired Pneumonia Due to Methicillin-resistant Staphylococcus Aureus
A Phase 3, Randomized, Double-Blind, Parallel-Group, Multinational Trial of Intravenous Telavancin Versus Vancomycin for Treatment of Hospital-Acquired Pneumonia With a Focus on Patients With Infections Due to Methicillin-Resistant Staphylococcus Aureus
Status: Enrolling
Updated: 12/31/1969
Baystate Medical Center
mi
from
Springfield, MA
Click here to add this to my saved trials
Developing Enhanced Prediction Models
Developing Enhanced Prediction Models to Identify Patients at Risk for Hospital Readmission by Collecting Patient-Generated Health Data
Status: Enrolling
Updated:  12/31/1969
Penn Medicine
mi
from
Philadelphia, PA
Developing Enhanced Prediction Models
Developing Enhanced Prediction Models to Identify Patients at Risk for Hospital Readmission by Collecting Patient-Generated Health Data
Status: Enrolling
Updated: 12/31/1969
Penn Medicine
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Pharmacist Impact on Pneumococcal Polysaccharide Vaccination Rates in Patients With Diabetes in a Supermarket Pharmacy Chain
Pharmacist Impact on Pneumococcal Polysaccharide Vaccination Rates in Patients With Diabetes in a Supermarket Pharmacy Chain
Status: Enrolling
Updated:  12/31/1969
Kroger Pharmacy
mi
from
Midlothian, VA
Pharmacist Impact on Pneumococcal Polysaccharide Vaccination Rates in Patients With Diabetes in a Supermarket Pharmacy Chain
Pharmacist Impact on Pneumococcal Polysaccharide Vaccination Rates in Patients With Diabetes in a Supermarket Pharmacy Chain
Status: Enrolling
Updated: 12/31/1969
Kroger Pharmacy
mi
from
Midlothian, VA
Click here to add this to my saved trials
Pharmacist Impact on Pneumococcal Polysaccharide Vaccination Rates in Patients With Diabetes in a Supermarket Pharmacy Chain
Pharmacist Impact on Pneumococcal Polysaccharide Vaccination Rates in Patients With Diabetes in a Supermarket Pharmacy Chain
Status: Enrolling
Updated:  12/31/1969
Kroger Pharmacy
mi
from
Richmond, VA
Pharmacist Impact on Pneumococcal Polysaccharide Vaccination Rates in Patients With Diabetes in a Supermarket Pharmacy Chain
Pharmacist Impact on Pneumococcal Polysaccharide Vaccination Rates in Patients With Diabetes in a Supermarket Pharmacy Chain
Status: Enrolling
Updated: 12/31/1969
Kroger Pharmacy
mi
from
Richmond, VA
Click here to add this to my saved trials
Pharmacist Impact on Pneumococcal Polysaccharide Vaccination Rates in Patients With Diabetes in a Supermarket Pharmacy Chain
Pharmacist Impact on Pneumococcal Polysaccharide Vaccination Rates in Patients With Diabetes in a Supermarket Pharmacy Chain
Status: Enrolling
Updated:  12/31/1969
Virginia Commonwealth University
mi
from
Richmond, VA
Pharmacist Impact on Pneumococcal Polysaccharide Vaccination Rates in Patients With Diabetes in a Supermarket Pharmacy Chain
Pharmacist Impact on Pneumococcal Polysaccharide Vaccination Rates in Patients With Diabetes in a Supermarket Pharmacy Chain
Status: Enrolling
Updated: 12/31/1969
Virginia Commonwealth University
mi
from
Richmond, VA
Click here to add this to my saved trials
Arginine Treatment of Acute Chest Syndrome (Pneumonia) in Sickle Cell Disease Patients
Arginine Therapy for Acute Chest Syndrome in Sickle Cell Disease
Status: Enrolling
Updated:  6/23/2005
Children's Hospital Oakland
mi
from
Oakland, CA
Arginine Treatment of Acute Chest Syndrome (Pneumonia) in Sickle Cell Disease Patients
Arginine Therapy for Acute Chest Syndrome in Sickle Cell Disease
Status: Enrolling
Updated: 6/23/2005
Children's Hospital Oakland
mi
from
Oakland, CA
Click here to add this to my saved trials
Comparative Study of EDP-420 Versus Another Antibiotic in the Treatment of Community Acquired Pneumonia
A Randomized, Double-Blinded, Parallel Group, Multicenter Study of EDP-420 Versus Telithromycin for the Treatment of Community Acquired Pneumonia
Status: Enrolling
Updated:  9/18/2006
Enanta Pharmaceuticals, Inc.
mi
from
Watertown, MA
Comparative Study of EDP-420 Versus Another Antibiotic in the Treatment of Community Acquired Pneumonia
A Randomized, Double-Blinded, Parallel Group, Multicenter Study of EDP-420 Versus Telithromycin for the Treatment of Community Acquired Pneumonia
Status: Enrolling
Updated: 9/18/2006
Enanta Pharmaceuticals, Inc.
mi
from
Watertown, MA
Click here to add this to my saved trials
Continuous Exhaled Breath Condensate pH in Mechanically Ventilated Patients
Phase 2 Continuous Exhaled Breath Condensate pH in Mechanically Ventilated Patients
Status: Enrolling
Updated:  8/6/2008
University of Virginia
mi
from
Charlottesville, VA
Continuous Exhaled Breath Condensate pH in Mechanically Ventilated Patients
Phase 2 Continuous Exhaled Breath Condensate pH in Mechanically Ventilated Patients
Status: Enrolling
Updated: 8/6/2008
University of Virginia
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Serum Procalcitonin Study in the Management of Ventilated Patients
Clinical Utility of Serum Procalcitonin in the Management of Ventilator-Associated Pneumonia
Status: Enrolling
Updated:  12/8/2008
University of Missouri
mi
from
Columbia, MO
Serum Procalcitonin Study in the Management of Ventilated Patients
Clinical Utility of Serum Procalcitonin in the Management of Ventilator-Associated Pneumonia
Status: Enrolling
Updated: 12/8/2008
University of Missouri
mi
from
Columbia, MO
Click here to add this to my saved trials
Corticosteroids Therapy on the Development of Interstitial Fibrosis in Patients With HIV Infection and Mild Pneumocystis Jirovecii Pneumonia (PCP)
Randomized, Non-Blinded Clinical Trial Examining the Effects of Oral Corticosteroids Therapy on the Development of Interstitial Fibrosis in Patients With HIV Infection and Pneumocystis Jirovecii Pneumonia (PCP) and pO2 of >70 at Presentation.
Status: Enrolling
Updated:  2/13/2009
George Washington University Medical Faculty Associates
mi
from
Washington,
Corticosteroids Therapy on the Development of Interstitial Fibrosis in Patients With HIV Infection and Mild Pneumocystis Jirovecii Pneumonia (PCP)
Randomized, Non-Blinded Clinical Trial Examining the Effects of Oral Corticosteroids Therapy on the Development of Interstitial Fibrosis in Patients With HIV Infection and Pneumocystis Jirovecii Pneumonia (PCP) and pO2 of >70 at Presentation.
Status: Enrolling
Updated: 2/13/2009
George Washington University Medical Faculty Associates
mi
from
Washington,
Click here to add this to my saved trials
Prophylactic Bronchoscopy After Inhalation Injury in Burn Patients
Prophylactic Bronchoscopy After Inhalation Injury in Burn Patients
Status: Enrolling
Updated:  10/16/2009
Hurley Medical Center
mi
from
Flint, MI
Prophylactic Bronchoscopy After Inhalation Injury in Burn Patients
Prophylactic Bronchoscopy After Inhalation Injury in Burn Patients
Status: Enrolling
Updated: 10/16/2009
Hurley Medical Center
mi
from
Flint, MI
Click here to add this to my saved trials
Use Of Procalcitonin Level For Guidance of The Treatment of Suspected Community Acquired Pneumonia
Use Of Procalcitonin Level For Guidance of The Treatment of Suspected Community Acquired Pneumonia
Status: Enrolling
Updated:  4/29/2010
Winthrop University Hospital
mi
from
Mineola, NY
Use Of Procalcitonin Level For Guidance of The Treatment of Suspected Community Acquired Pneumonia
Use Of Procalcitonin Level For Guidance of The Treatment of Suspected Community Acquired Pneumonia
Status: Enrolling
Updated: 4/29/2010
Winthrop University Hospital
mi
from
Mineola, NY
Click here to add this to my saved trials
Genetic Variation and Immune Responses After Injury
Genetics of Innate Immune Response After Burn Trauma
Status: Enrolling
Updated:  8/23/2010
UT Southwestern Medical Center at Dallas
mi
from
Dallas, TX
Genetic Variation and Immune Responses After Injury
Genetics of Innate Immune Response After Burn Trauma
Status: Enrolling
Updated: 8/23/2010
UT Southwestern Medical Center at Dallas
mi
from
Dallas, TX
Click here to add this to my saved trials
Observational Study of Sepsis and Pneumonia to Develop Diagnostic Tests
Plasma Protein Biomarker Based Diagnostics of Outcome in Sepsis & CAP
Status: Enrolling
Updated:  11/5/2010
Henry Ford Hospital
mi
from
Detroit, MI
Observational Study of Sepsis and Pneumonia to Develop Diagnostic Tests
Plasma Protein Biomarker Based Diagnostics of Outcome in Sepsis & CAP
Status: Enrolling
Updated: 11/5/2010
Henry Ford Hospital
mi
from
Detroit, MI
Click here to add this to my saved trials
Observational Study of Sepsis and Pneumonia to Develop Diagnostic Tests
Plasma Protein Biomarker Based Diagnostics of Outcome in Sepsis & CAP
Status: Enrolling
Updated:  11/5/2010
Duke Univ Med Ctr
mi
from
Durham, NC
Observational Study of Sepsis and Pneumonia to Develop Diagnostic Tests
Plasma Protein Biomarker Based Diagnostics of Outcome in Sepsis & CAP
Status: Enrolling
Updated: 11/5/2010
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Observational Study of Sepsis and Pneumonia to Develop Diagnostic Tests
Plasma Protein Biomarker Based Diagnostics of Outcome in Sepsis & CAP
Status: Enrolling
Updated:  11/5/2010
Durham VA Medical Center
mi
from
Durham, NC
Observational Study of Sepsis and Pneumonia to Develop Diagnostic Tests
Plasma Protein Biomarker Based Diagnostics of Outcome in Sepsis & CAP
Status: Enrolling
Updated: 11/5/2010
Durham VA Medical Center
mi
from
Durham, NC
Click here to add this to my saved trials
Anxiety Self-Management for ICU Patients Receiving Mechanical Ventilation
Reducing Sedative Exposure in Ventilated ICU Patients
Status: Enrolling
Updated:  1/13/2011
University of Minnesota Medical Center
mi
from
Minneapolis, MN
Anxiety Self-Management for ICU Patients Receiving Mechanical Ventilation
Reducing Sedative Exposure in Ventilated ICU Patients
Status: Enrolling
Updated: 1/13/2011
University of Minnesota Medical Center
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Evaluation of Rosiglitazone Anti-inflammatory Effect With FDG-PET Imaging
Noninvasive Quantification of the Pulmonary Anti-inflammatory Effect of Rosiglitazone
Status: Enrolling
Updated:  7/28/2011
Washington University/Barnes Jewish Hospital
mi
from
St. Louis, MO
Evaluation of Rosiglitazone Anti-inflammatory Effect With FDG-PET Imaging
Noninvasive Quantification of the Pulmonary Anti-inflammatory Effect of Rosiglitazone
Status: Enrolling
Updated: 7/28/2011
Washington University/Barnes Jewish Hospital
mi
from
St. Louis, MO
Click here to add this to my saved trials
PET Imaging of Endotoxin-induced iNOS Activation
PET Imaging of Endotoxin-induced iNOS Activation in Healthy Volunteers
Status: Enrolling
Updated:  7/29/2011
Washington University School of Medicne
mi
from
St. Louis, MO
PET Imaging of Endotoxin-induced iNOS Activation
PET Imaging of Endotoxin-induced iNOS Activation in Healthy Volunteers
Status: Enrolling
Updated: 7/29/2011
Washington University School of Medicne
mi
from
St. Louis, MO
Click here to add this to my saved trials
Phase I Safety Trial of Streptococcus Pneumoniae Whole Cell Vaccine (SPWCV) + Alum in Healthy Adults
A Phase 1 Randomized, Double-Blind, Dose-Escalation Study to Assess the Safety, Tolerability and Immunogenicity of Inactivated Streptococcus Pneumoniae Whole Cell Vaccine Formulated With Alum (SPWCV+Alum) in Healthy Adults
Status: Enrolling
Updated:  3/14/2012
Comprehensive Clinical Development
mi
from
Tacoma, WA
Phase I Safety Trial of Streptococcus Pneumoniae Whole Cell Vaccine (SPWCV) + Alum in Healthy Adults
A Phase 1 Randomized, Double-Blind, Dose-Escalation Study to Assess the Safety, Tolerability and Immunogenicity of Inactivated Streptococcus Pneumoniae Whole Cell Vaccine Formulated With Alum (SPWCV+Alum) in Healthy Adults
Status: Enrolling
Updated: 3/14/2012
Comprehensive Clinical Development
mi
from
Tacoma, WA
Click here to add this to my saved trials
CDC Prevention Epicenters Wake Up and Breathe Collaborative
CDC Prevention Epicenters Wake Up and Breathe Collaborative
Status: Enrolling
Updated:  5/1/2012
Chicago Prevention Epicenter
mi
from
Chicago, IL
CDC Prevention Epicenters Wake Up and Breathe Collaborative
CDC Prevention Epicenters Wake Up and Breathe Collaborative
Status: Enrolling
Updated: 5/1/2012
Chicago Prevention Epicenter
mi
from
Chicago, IL
Click here to add this to my saved trials
CDC Prevention Epicenters Wake Up and Breathe Collaborative
CDC Prevention Epicenters Wake Up and Breathe Collaborative
Status: Enrolling
Updated:  5/1/2012
North Shore Medical Center
mi
from
Peabody, MA
CDC Prevention Epicenters Wake Up and Breathe Collaborative
CDC Prevention Epicenters Wake Up and Breathe Collaborative
Status: Enrolling
Updated: 5/1/2012
North Shore Medical Center
mi
from
Peabody, MA
Click here to add this to my saved trials
CDC Prevention Epicenters Wake Up and Breathe Collaborative
CDC Prevention Epicenters Wake Up and Breathe Collaborative
Status: Enrolling
Updated:  5/1/2012
Washington University Prevention Epicenter
mi
from
St. Louis, MO
CDC Prevention Epicenters Wake Up and Breathe Collaborative
CDC Prevention Epicenters Wake Up and Breathe Collaborative
Status: Enrolling
Updated: 5/1/2012
Washington University Prevention Epicenter
mi
from
St. Louis, MO
Click here to add this to my saved trials
CDC Prevention Epicenters Wake Up and Breathe Collaborative
CDC Prevention Epicenters Wake Up and Breathe Collaborative
Status: Enrolling
Updated:  5/1/2012
Duke University Prevention Epicenter
mi
from
Durham, NC
CDC Prevention Epicenters Wake Up and Breathe Collaborative
CDC Prevention Epicenters Wake Up and Breathe Collaborative
Status: Enrolling
Updated: 5/1/2012
Duke University Prevention Epicenter
mi
from
Durham, NC
Click here to add this to my saved trials
CDC Prevention Epicenters Wake Up and Breathe Collaborative
CDC Prevention Epicenters Wake Up and Breathe Collaborative
Status: Enrolling
Updated:  5/1/2012
University of Pennsylvania Prevention Epicenter
mi
from
Philadelphia, PA
CDC Prevention Epicenters Wake Up and Breathe Collaborative
CDC Prevention Epicenters Wake Up and Breathe Collaborative
Status: Enrolling
Updated: 5/1/2012
University of Pennsylvania Prevention Epicenter
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Use of Ceftaroline in Hospitalized Patients With Community Acquired Pneumonia
Ceftaroline Fosamil Versus Standard of Care for Community Acquired Bacterial Pneumonia (CABP): Clinical Outcomes Among Hospitalized Adults at a Single United States Hospital
Status: Enrolling
Updated:  5/23/2012
Albany Medical College
mi
from
Albany, NY
Use of Ceftaroline in Hospitalized Patients With Community Acquired Pneumonia
Ceftaroline Fosamil Versus Standard of Care for Community Acquired Bacterial Pneumonia (CABP): Clinical Outcomes Among Hospitalized Adults at a Single United States Hospital
Status: Enrolling
Updated: 5/23/2012
Albany Medical College
mi
from
Albany, NY
Click here to add this to my saved trials
Evaluation of an Oral Nutritional Supplement in Older Hospitalized Patients
Evaluation of an Oral Nutritional Supplement Containing AN 777 in Older Hospitalized Patients
Status: Enrolling
Updated:  6/15/2012
Horizon Research Group, Inc.
mi
from
Mobile, AL
Evaluation of an Oral Nutritional Supplement in Older Hospitalized Patients
Evaluation of an Oral Nutritional Supplement Containing AN 777 in Older Hospitalized Patients
Status: Enrolling
Updated: 6/15/2012
Horizon Research Group, Inc.
mi
from
Mobile, AL
Click here to add this to my saved trials
Evaluation of an Oral Nutritional Supplement in Older Hospitalized Patients
Evaluation of an Oral Nutritional Supplement Containing AN 777 in Older Hospitalized Patients
Status: Enrolling
Updated:  6/15/2012
Northwestern University
mi
from
Chicago, IL
Evaluation of an Oral Nutritional Supplement in Older Hospitalized Patients
Evaluation of an Oral Nutritional Supplement Containing AN 777 in Older Hospitalized Patients
Status: Enrolling
Updated: 6/15/2012
Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials